Share
Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift.
Share
We’ve masked, we’ve vaccinated, we’ve boosted — but are we underutilizing technology that could contain the pandemic because we don’t trust it?
Share
Virginia Tech professor Raffaella De Vita has been awarded a National Science Foundation award to study the biomechanics of gender affirming surgery.
Share
Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.
Share
A cancer stem cell research company founded by Fralin Biomedical Research Institute at VTC scientists is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers.
Share
Mental time travel — transporting someone from the present through imagining a personal, positive future event — has been proven to help reduce alcohol, tobacco, and drug use.
Share
If you have a business idea and you want to maximize your chances of turning that idea into a successful reality, it’s important to do your research proactively.
Share
Through collaboration that incorporates the use of computational modeling, data, and virology, a group of Virginia Tech researchers tackles the latest questions surrounding COVID-19.
Share
Tamp down one cyberattack, and another pops up — threatening both livelihoods and lives across industries and sectors.
Share
Leading global aerospace and defense company Northrop Grumman has become a key strategic partner of the Virginia Tech Innovation Campus by making a $12.5 million commitment to support research and teaching in quantum information science and engineering.
Local news is in “serious jeopardy,” according to experts. Pitch in and help AFP continue to deliver news to the Valley, Virginia and beyond.